Récidive de la douleur après chirurgie pour endométriose profonde : pourquoi ? Que faire ?

B Borghese, Bruno Borghese, Santulli P, Piétro Santulli, P Santulli, Isabelle Streuli, I. Streuli, Marie-Christine Lafay-Pillet, M-C. Lafay-Pillet, Lafay-Pillet MC, D. de Ziegler, de Ziegler D, C. Chapron, Chapron C, Charles Chapron
Journal de gynecologie, obstetrique et biologie de la reproduction · 2012 · vol. 43(1) , pp. 12–18 · doi:10.1016/j.jgyn.2012.11.009 · PMID:23265672 · W2031704395
review OA: closed CC0 ⤵ 17 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This review examines the reasons for recurrent pain after deep endometriosis surgery and discusses potential management strategies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Recurrence of deep endometriosis remains a major issue in the management of endometriosis. The main cause for recurrence appears to be an incomplete excisional surgery. Therefore, the goal of the primary surgery should be the complete resection of all endometriotic lesions. If surgical skills cannot meet this objective it seems preferable to refer the patient to a center with a recognized expertise in this field rather than performing an incomplete surgery. It seems also possible to tailor the indications according to the symptoms, especially when endometriosis affects the bladder in association with an asymptomatic vaginal and/or rectal involvement. This strategy does not increase the rate of recurrence. Postoperative medical treatment based on ovarian function suppression is attractive as it diminishes the recurrence rate. Facing the recurrence, appropriate assessment of the benefit risk balance must be performed. Medical treatment is an option. When surgery is chosen, it seems interesting to discuss carefully the indication of hysterectomy with bilateral oophorectomy, especially for women over 40 years old with no desire for pregnancy and/or symptomatic adenomyosis. Risks of induced ovarian castration must be taken into account.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

MeSH descriptors

Endometriosis Pelvic Pain Pelvic Pain Peritoneal Diseases Danazol Danazol Endometriosis Endometriosis Endometriosis Female Humans Intestinal Diseases Intestinal Diseases Intestinal Diseases Intestinal Diseases Molecular Targeted Therapy Molecular Targeted Therapy Norethindrone Norethindrone Pelvic Pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (47)

Cited by (16)

Source provenance

europepmc
last seen: 2026-09-02T07:05:44.937405+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:58.344756+00:00
unpaywall
last seen: 2026-09-02T07:26:43.000666+00:00
License: CC0 · commercial use OK